Advertisement
Advertisement

OKUR

OKUR logo

OnKure Therapeutics, Inc. Class A Common Stock

3.91
USD
Sponsored
-0.05
-1.26%
May 08, 15:58 UTC -4
Closed
exchange

After-Market

3.74

-0.17
-4.35%

OnKure Therapeutics, Inc. Class A Common Stock Profile

About

OnKure Inc. is a clinical-stage biopharmaceutical company. It focused on the discovery and development of precision medicines which target biologically validated drivers of cancers. The company is currently developing OKI-219. OnKure Inc., formerly known as Reneo Pharmaceuticals Inc., is based in IRVINE, Calif.

Info & Links

CEO

Nicholas A. Saccomano

Headquarters

6707 Winchester Circle, Suite 400
Boulder, CO 80301, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://onkuretherapeutics.com

Auditor

KPMG LLP

Share holders

36

Employees

45

OnKure Therapeutics, Inc. Class A Common Stock Statistics

Valuation Measures

Market Capitalization2

151.08M

Enterprise Value

92.03M

Enterprise Value/EBITDA(ttm)

-1.48

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.04

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-81.69%

Return on Invested Capital(ttm)

-83.42%

Return on Assets(ttm)

-74.19%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-62.12M

Net Income Available to Common(ttm)

-59.52M

Diluted EPS(ttm)

-4.41

Share Statistics

Beta (5Y Monthly)

0.15

52-Week Change

95.50%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

13.67M

Dividend Yield

0.00%

Float4

13.36M

% Held by Insiders

2.30%

% Held by Institutions

90.98%

Balance Sheet

Total Cash(mrq)

59.05M

Total Cash Per Share(mrq)

4.32

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

10.28%

Quick Ratio(mrq)

10.28%

Book Value Per Share(mrq)

4.11

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.83

Free Cash Flow(ytd)

-51.87M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement